Arkolith/Insider Trading/STRO/Form 4

Chung Jane

Chief Executive Officer, DirectorSUTRO BIOPHARMA, INC. (STRO) · full profile →Form 4 · filed Oct 16, 2025
Net Buying
Open-Market Buys
$10K
Open-Market Sells
$0
Net Open-Market Flow
$10K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Oct 15, 2025Buy(P)13K$0.80$10K123K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001872398-25-000004) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML